CN Patent

CN110248948A — 墨蝶呤及其盐的多晶型物

Assigned to PTC Therapeutics MP Inc · Expires 2019-09-17 · 7y expired

What this patent protects

公开了选自多晶型物A、B、C、D、E、F和G的墨蝶呤游离碱的晶形及其组合，以及墨蝶呤的盐的结晶多晶型物。还公开了含有一种或更多种这样的多晶型物的药物组合物和制备这样的多晶型物的方法。墨蝶呤可用于治疗与低细胞内BH4水平相关的多种疾病，例如苯丙酮尿症。

USPTO Abstract

公开了选自多晶型物A、B、C、D、E、F和G的墨蝶呤游离碱的晶形及其组合，以及墨蝶呤的盐的结晶多晶型物。还公开了含有一种或更多种这样的多晶型物的药物组合物和制备这样的多晶型物的方法。墨蝶呤可用于治疗与低细胞内BH4水平相关的多种疾病，例如苯丙酮尿症。

Drugs covered by this patent

Patent Metadata

Patent number
CN110248948A
Jurisdiction
CN
Classification
—
Expires
2019-09-17
Drug substance claim
No
Drug product claim
No
Assignee
PTC Therapeutics MP Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.